1. Home
  2. KLIC vs LGND Comparison

KLIC vs LGND Comparison

Compare KLIC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLIC
  • LGND
  • Stock Information
  • Founded
  • KLIC 1951
  • LGND 1987
  • Country
  • KLIC United States
  • LGND United States
  • Employees
  • KLIC N/A
  • LGND N/A
  • Industry
  • KLIC Semiconductors
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLIC Technology
  • LGND Health Care
  • Exchange
  • KLIC Nasdaq
  • LGND Nasdaq
  • Market Cap
  • KLIC 2.4B
  • LGND 2.2B
  • IPO Year
  • KLIC N/A
  • LGND 1992
  • Fundamental
  • Price
  • KLIC $35.59
  • LGND $105.62
  • Analyst Decision
  • KLIC Strong Buy
  • LGND Strong Buy
  • Analyst Count
  • KLIC 5
  • LGND 6
  • Target Price
  • KLIC $52.00
  • LGND $145.00
  • AVG Volume (30 Days)
  • KLIC 627.5K
  • LGND 125.0K
  • Earning Date
  • KLIC 04-30-2025
  • LGND 05-06-2025
  • Dividend Yield
  • KLIC 2.31%
  • LGND N/A
  • EPS Growth
  • KLIC N/A
  • LGND N/A
  • EPS
  • KLIC 0.06
  • LGND N/A
  • Revenue
  • KLIC $701,167,000.00
  • LGND $167,133,000.00
  • Revenue This Year
  • KLIC $7.12
  • LGND $16.90
  • Revenue Next Year
  • KLIC $19.40
  • LGND $18.27
  • P/E Ratio
  • KLIC $583.14
  • LGND N/A
  • Revenue Growth
  • KLIC N/A
  • LGND 27.28
  • 52 Week Low
  • KLIC $35.04
  • LGND $67.72
  • 52 Week High
  • KLIC $53.71
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • KLIC 30.97
  • LGND 37.78
  • Support Level
  • KLIC $35.04
  • LGND $105.02
  • Resistance Level
  • KLIC $38.18
  • LGND $111.22
  • Average True Range (ATR)
  • KLIC 1.44
  • LGND 6.67
  • MACD
  • KLIC -0.15
  • LGND -1.39
  • Stochastic Oscillator
  • KLIC 8.03
  • LGND 10.07

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: